INSIGHTS ON SOLID DOSE MANUFACTURING

  • Compaction Simulation For Tablet Technology Transfer And Scale-Up
    7/15/2026

    Compaction simulation de-risked tech transfer for a 40 mg fexuprazan tablet by defining optimal roller compaction and lubrication parameters before scale-up. Access the full case study to see the data.

  • Blister Solutions
    3/4/2025

    With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.

  • NanoImprove The Performance Of Your Formulations
    9/24/2024

    Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.

  • Advancing High Potency Manufacturing
    4/13/2026

    Advance potent drug manufacturing through tighter containment, thoughtful process engineering, and closed handling that protects workers while improving efficiency and scale.

  • Exploring The Future Of Tablet Compression Across Emerging Industries
    11/18/2025

    Many growing industries face universal tablet compression challenges, demanding better tooling, tighter process control, and more integrated data to ensure product consistency and reliable scale-up.

SOLID DOSE MANUFACTURING SOLUTIONS

  • 30" Vector Hi-Coater Coating Pan, stainless steel construction, for model VHC-1355 coater, built 2002.

  • Learn how closed systems, advanced facilities, and flexible batch strategies support safe development and reliable commercial supply.

  • Natoli Scientific takes pride in its comprehensive USP<1062> Tablet Compression Characterization services, tailored to address the complexities of tableting in pharmaceutical manufacturing. Staying true to the parameters outlined in the United States Pharmacopeia (USP) Chapter 1062, our approach meticulously evaluates tablet compression behaviors. By thoroughly characterizing the compression profile, we can pinpoint the optimal compression force required to form a cohesive tablet without applying undue stress that could lead to capping — the separation of tablet tops during or after the compression phase.

  • Used Glatt GPCG2 Fluid Bed Granulator System, SN FM10330, Manufactured 2008, with 6" Wurster Installed and additional 6 liter top spray product insert, box of spray nozzles and spray nozzle parts, Stainless Steel base (In Crate).

  • Finding a strategic CDMO partner that will offer tailored solutions for your late phase clinical and commercial needs, mitigate risks, and bolster your supply chain is crucial for meeting project milestones on time.